Bernstein initiated coverage on Waters with a new price target
$WAT
Biotechnology: Laboratory Analytical Instruments
Industrials
Bernstein initiated coverage of Waters with a rating of Mkt Perform and set a new price target of $280.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/10/2025 | $430.00 | Mkt Perform → Outperform | Bernstein |
| 12/23/2024 | Sector Perform | Scotiabank | |
| 10/8/2024 | $355.00 → $415.00 | Hold → Buy | Jefferies |
| 8/28/2024 | $380.00 | Overweight | Wells Fargo |
| 8/1/2024 | $325.00 → $375.00 | Market Perform → Outperform | Leerink Partners |
| 6/3/2024 | $320.00 | Hold | Jefferies |
| 11/13/2023 | $270.00 → $230.00 | Equal Weight → Underweight | Barclays |
| 9/28/2023 | $280.00 | Mkt Perform | Bernstein |
4 - WATERS CORP /DE/ (0001000697) (Issuer)
4 - WATERS CORP /DE/ (0001000697) (Issuer)
4 - WATERS CORP /DE/ (0001000697) (Issuer)
4 - WATERS CORP /DE/ (0001000697) (Issuer)
MILFORD, Mass., Jan. 17, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q4 2024 financial results conference call live on Wednesday, February 12th, 2025 at 8:00 a.m. Eastern Time. A live webcast of the presentation will be available on Waters Investor Relations website at https://ir.waters.com. A replay of the webcast will also be available until at least March 12th, 2025, at midnight Eastern Time. About Waters Corporation Waters Corporation (NYSE:WAT), a global leader in analytical instruments and software, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, food, and environmental sciences for more than 65 years.
Highlights Sales of $740 million exceeded guidance, grew 4% as reported and 4% in constant currencyInstruments returned to growth; recurring revenue grew high single-digits in constant currencyAll reported regions returned to growth in the quarter; sales grew across all end markets, led by Pharma & IndustrialGAAP EPS of $2.71 and non-GAAP EPS of $2.93 significantly exceeded guidance, led by strong operational performance and better-than-expected market conditionsRaised full-year sales and EPS guidance, with 5% to 7% constant currency growth expected in the fourth quarterThird Quarter 2024 MILFORD, Mass., Nov. 1, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) today announced its financial
MILFORD, Mass., Oct. 7, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q3 2024 financial results conference call live on Friday, November 1st, 2024 at 8:00 a.m. Eastern Time. A live webcast of the presentation will be available on Waters Investor Relations website at https://ir.waters.com. A replay of the webcast will also be available until at least November 29th, 2024, at midnight Eastern Time. About Waters Corporation Waters Corporation (NYSE:WAT), a global leader in analytical instruments and software, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, food, and environmental sciences for more than 65 years. W
8-K - WATERS CORP /DE/ (0001000697) (Filer)
8-K/A - WATERS CORP /DE/ (0001000697) (Filer)
10-Q - WATERS CORP /DE/ (0001000697) (Filer)
Bernstein upgraded Waters from Mkt Perform to Outperform and set a new price target of $430.00
Scotiabank initiated coverage of Waters with a rating of Sector Perform
Jefferies upgraded Waters from Hold to Buy and set a new price target of $415.00 from $355.00 previously
MILFORD, Mass., Jan. 17, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q4 2024 financial results conference call live on Wednesday, February 12th, 2025 at 8:00 a.m. Eastern Time. A live webcast of the presentation will be available on Waters Investor Relations website at https://ir.waters.com. A replay of the webcast will also be available until at least March 12th, 2025, at midnight Eastern Time. About Waters Corporation Waters Corporation (NYSE:WAT), a global leader in analytical instruments and software, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, food, and environmental sciences for more than 65 years.
MILFORD, Mass., Jan. 10, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that it will host an Investor Day on Wednesday, March 5th, 2025, in New York City, starting at 8:30 AM ET. The event will feature presentations by members of the senior management team, who will discuss business initiative achievements, new strategic priorities, and our vision for future shareholder value creation. A Q&A session will follow. In-Person AttendanceTo request in-person attendance at this event, please click here or visit the Waters Investor Relations website at https://ir.waters.com, under 'Events'. WebcastA live webcast will be available the day of the event. To register for the webcast, plea
MILFORD, Mass., Dec. 23, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced it has been named to the Dow Jones Sustainability North America Index (DJSI North America) for the fourth consecutive year, based on the strength of its enterprise-wide sustainability practices. The DJSI is informed by the annual evaluation by the S&P Global Corporate Sustainability Assessment (CSA). Waters has been named to the DJSI with a ranking that surpasses industry averages across all sustainability categories."We are pleased that Waters has once again been named to the DJSI for our ongoing progress towards our commitment to sustainability. In 2023, we achieved our greenhouse gas reduction target two
SC 13G/A - WATERS CORP /DE/ (0001000697) (Subject)
SC 13G/A - WATERS CORP /DE/ (0001000697) (Subject)
SC 13G/A - WATERS CORP /DE/ (0001000697) (Subject)
MILFORD, Mass., Aug. 14, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) today announced the appointment of Heather Knight to its Board of Directors effective August 14, 2024. Ms. Knight currently serves as Executive Vice President and Group President, Medical Products and Therapies at Baxter International. Heather is an accomplished leader who brings decades of experience across the pharma and medical device industries."Heather is an accomplished leader who brings decades of experience across the pharmaceutical and medical device industries, with a proven track record for
Waters™ Corporation (NYSE:WAT) today announced the appointment of Richard Fearon to its Board of Directors, effective March 27, 2023. Mr. Fearon is the former Vice Chairman and Chief Financial and Planning Officer of Eaton Corporation, a multinational power management company. "Rick's expertise is at the intersection of financial excellence, strategic development and transformation, which are the key pillars of Waters' growth plan. We are confident that Rick's unique skillset will complement our Board well and we look forward to benefiting from his insights as we continue to drive value for shareholders," said Dr. Flemming Ornskov, Chairman of the Board. Dr. Udit Batra, CEO and President,
Waters Corporation (NYSE:WAT) today announced the appointment of Dan Brennan and Mark Vergnano, to its Board of Directors, effective November 23, 2022. Mr. Brennan currently serves as Executive Vice President and Chief Financial Officer of Boston Scientific Corporation, a global medical device company, and Mr. Vergnano is the former Chairman, President and Chief Executive Officer of The Chemours Company, a chemistry company. "Dan and Mark are outstanding leaders whose decades of experience in the medical device and chemistry industries will add tremendous value as Waters continues to execute its exciting growth strategy," said Dr. Flemming Ornskov, Chairman of the Board. "These appointment